42 CFR § 423.1002 - Definitions.
---
identifier: "/us/cfr/t42/s423.1002"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "42 CFR § 423.1002 - Definitions."
title_number: 42
title_name: "Public Health"
section_number: "423.1002"
section_name: "Definitions."
chapter_name: "CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "B"
subchapter_name: "MEDICARE PROGRAM"
part_number: "423"
part_name: "VOLUNTARY MEDICARE PRESCRIPTION DRUG BENEFIT"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "42 U.S.C. 1302, 1306, 1395w-101 through 1395w-152, and 1395hh."
regulatory_source: "70 FR 4525, Jan. 28, 2005, unless otherwise noted."
cfr_part: "423"
---
# 423.1002 Definitions.
As used in this subpart—
*Affected party* means any Part D sponsor or manufacturer (as defined in § 423.2305) impacted by an initial determination or, if applicable, by a subsequent determination or decision issued under this part, and “party” means the affected party or CMS, as appropriate.
*ALJ* stands for Administrative Law Judge.
*Departmental Appeals Board or Board* means a Board established in the Office of the Secretary to provide impartial review of disputed decisions made by the operating components of the Department.
*Part D sponsor* has the meaning given the term in 423.4.
[72 FR 68736, Dec. 5, 2007, as amended 77 FR 22171, Apr. 12, 2012]